July 13 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:VRX) VRX.TO
* Valeant announces redemption of remaining approximately $500 million aggregate principal amount of its outstanding 6.75% senior notes due 2018
* Valeant announces redemption of remaining approximately $500 million aggregate principal amount of its outstanding 6.75% senior notes due 2018
* Valeant - upon redemption, Valeant's debt reduction will total more than $4.8 billion since end of first-quarter 2016
* Valeant - upon redemption of notes, Valeant will have reduced its debt by more than $4.8 billion since end of q1 of 2016
* Valeant - continues to reiterate its expectation to pay down $5 billion in debt from divestiture proceeds and free cash flow within 18 months of august 2016
* Valeant - additionally, company will have no significant debt maturities and no mandatory amortization requirements through 2019. Source text for Eikon: ID:nCNW6Chk0a Further company coverage: VRX.TO